2011, Number S1
<< Back Next >>
Rev Mex Anest 2011; 34 (S1)
New anticoagulants and regional anesthesia
Portela-Ortiz JM, Mille-Loera JE, Aréchiga-Ornelas G
Language: Spanish
References: 11
Page: 95-97
PDF size: 480.72 Kb.
Text Extraction
No abstract
REFERENCES
Geerts WH, Bergquist D, Pineo GF. Prevention of venous thromboembolism: American College of Chest Physicians evidence based clinical practice guidelines. Chest 2008;133:381-453.
Lassen MR, Ageno W, Borris LC. Rivaroxaban for thromboprophylaxis after total knee arthroplasty. N Eng J Med 2008;358:2776-2785.
Anderson FA, Wheeler HB, Goldberg RJ. A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Inter Med 1991;151:933-938.
Wong PC, Crain EJ, Xin B. Apixaban, an oral, direct and selective factor Xa inhibitor: In vitro antithrombotic and antihemostatic studies. J Thromb Haemost 2007;6:820-829.
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ. Venous thromboembolism risk and prophylaxis in the acute hospital care setting: A multinational cross section study. Lancet 2008;371:387-394.
Matheson AJ, Goa KL. Desirudin: A review of its use in the management of thrombotic disorders. Drugs 2000;60:679-700.
Eriksson BI, Quinlan DJ, Weitz JI. Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors development. Clin Pharmacokinet 2009;48:1-22.
Walenga JM, Prechel M, Jeske WP. Rivaroxaban an oral direct factor Xa inhibitor has potential for the management of patients with heparin induced thrombocytopenia. Br J Haematol 2008;142:92-99.
Levy JH, Key NS, Azran MS. Novel oral anticoagulants: Implications in the perioperative setting. Anesthesiology 2010;113:726-745.
Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Samama ChM. Regional anaesthesia and antithrombotic agents: Recommendations of the European Society of Anaesthesiology. Eur J Anaesth 2010;27:999-1015.
Squizzato A, Romualdi E, Dentali F, Ageno W. The new oral anticoagulants, do they change the benefit vs risk for thromboprophylaxis in association to ambulatory surgery? Curr Op Anesth 2010;23: 722-725.